Insigneo Advisory Services LLC Takes $336,000 Position in Stryker Corporation (NYSE:SYK)

Insigneo Advisory Services LLC bought a new stake in shares of Stryker Corporation (NYSE:SYK - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 902 shares of the medical technology company's stock, valued at approximately $336,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. NBT Bank N A NY grew its stake in shares of Stryker by 17.5% during the first quarter. NBT Bank N A NY now owns 4,984 shares of the medical technology company's stock valued at $1,855,000 after buying an additional 744 shares during the last quarter. Chicago Capital LLC lifted its stake in shares of Stryker by 0.7% in the 1st quarter. Chicago Capital LLC now owns 196,419 shares of the medical technology company's stock valued at $73,117,000 after acquiring an additional 1,367 shares during the last quarter. WD Rutherford LLC boosted its holdings in Stryker by 2.1% during the 1st quarter. WD Rutherford LLC now owns 10,857 shares of the medical technology company's stock valued at $3,765,000 after acquiring an additional 227 shares during the period. Fortitude Advisory Group L.L.C. lifted its position in Stryker by 3.8% in the first quarter. Fortitude Advisory Group L.L.C. now owns 1,068 shares of the medical technology company's stock valued at $370,000 after purchasing an additional 39 shares during the last quarter. Finally, Grimes & Company Inc. lifted its position in Stryker by 0.8% in the first quarter. Grimes & Company Inc. now owns 8,343 shares of the medical technology company's stock valued at $3,106,000 after purchasing an additional 66 shares during the last quarter. Institutional investors own 77.09% of the company's stock.

Insider Buying and Selling at Stryker

In other news, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total value of $75,392,000.00. Following the sale, the director now directly owns 3,417,326 shares of the company's stock, valued at approximately $1,288,195,208.96. This represents a 5.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 5.90% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the stock. Sanford C. Bernstein set a $450.00 target price on shares of Stryker in a research note on Monday, May 5th. Evercore ISI dropped their target price on shares of Stryker from $400.00 to $390.00 and set an "outperform" rating for the company in a report on Friday, May 2nd. BTIG Research set a $403.00 target price on Stryker and gave the stock a "buy" rating in a research note on Monday, April 14th. Citigroup reaffirmed a "buy" rating and set a $455.00 price target (up previously from $443.00) on shares of Stryker in a research report on Thursday, May 22nd. Finally, JMP Securities reiterated a "market perform" rating on shares of Stryker in a report on Monday, May 5th. Four analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, Stryker has a consensus rating of "Moderate Buy" and a consensus price target of $427.30.

Stryker Stock Down 0.0%

Shares of NYSE:SYK traded down $0.15 during midday trading on Thursday, reaching $373.22. The company's stock had a trading volume of 854,682 shares, compared to its average volume of 1,333,573. The company has a quick ratio of 1.00, a current ratio of 1.64 and a debt-to-equity ratio of 0.69. The firm has a 50 day moving average of $373.92 and a 200-day moving average of $375.52. The firm has a market capitalization of $142.45 billion, a P/E ratio of 50.43, a PEG ratio of 2.82 and a beta of 0.91. Stryker Corporation has a 12-month low of $314.93 and a 12-month high of $406.19.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.84 earnings per share for the quarter, topping analysts' consensus estimates of $2.73 by $0.11. Stryker had a net margin of 12.31% and a return on equity of 23.74%. The business had revenue of $5.87 billion for the quarter, compared to analysts' expectations of $5.68 billion. During the same quarter in the prior year, the company earned $2.50 earnings per share. The business's revenue was up 11.9% compared to the same quarter last year. On average, research analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be given a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a yield of 0.90%. The ex-dividend date is Monday, June 30th. Stryker's dividend payout ratio (DPR) is presently 45.41%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.